Vascular Endothelial Growth Factor (VEGF) and VEGF Receptor Inhibitors in Health and Disease

被引:1
作者
Broussy, Sylvain [1 ]
机构
[1] Univ Paris Cite, UMR CNRS 8038, U1268 INSERM, CiTCoM,UFR Pharm Fac Sante, F-75006 Paris, France
关键词
D O I
10.3390/ph17070959
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
引用
收藏
页数:3
相关论文
共 18 条
[1]   Targeting angiogenesis in oncology, ophthalmology and beyond [J].
Cao, Yihai ;
Langer, Robert ;
Ferrara, Napoleone .
NATURE REVIEWS DRUG DISCOVERY, 2023, 22 (06) :476-495
[2]   Metabolic and conformational stabilization of a VEGF-mimetic beta-hairpin peptide by click-chemistry [J].
De Rosa, Lucia ;
Capasso, Domenica ;
Diana, Donatella ;
Stefania, Rachele ;
Di Stasi, Rossella ;
Fattorusso, Roberto ;
D'Andrea, Luca Domenico .
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2021, 222
[3]   Conformationally Constrained Peptides with High Affinity to the Vascular Endothelial Growth Factor [J].
Guryanov, Ivan ;
Korzhikov-Vlakh, Viktor ;
Bhattacharya, Madhushree ;
Biondi, Barbara ;
Masiero, Giulia ;
Formaggio, Fernando ;
Tennikova, Tatiana ;
Urtti, Arto .
JOURNAL OF MEDICINAL CHEMISTRY, 2021, 64 (15) :10900-10907
[4]   Pharmacodynamic and Antitumor Activity of BI 836880, a Dual Vascular Endothelial Growth Factor and Angiopoietin 2 Inhibitor, Alone and Combined with Programmed Cell Death Protein-1 Inhibition [J].
Hofmann, Irmgard ;
Baum, Anke ;
Hofmann, Marco H. ;
Trapani, Francesca ;
Reichel-Voda, Claudia ;
Ehrensperger, Diane ;
Aichinger, Martin ;
Ebner, Florian ;
Budano, Nicole ;
Schweifer, Norbert ;
Sykora, Martina ;
Depla, Erik ;
Boucneau, Joachim ;
Gschwind, Andreas ;
Kraut, Norbert ;
Hilberg, Frank ;
Kunkele, Klaus-Peter .
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 2023, 384 (03) :331-342
[5]   Targeted therapy of angiogenesis using anti-VEGFR2 and anti-NRP-1 nanobodies [J].
Karami, Elmira ;
Naderi, Shamsi ;
Roshan, Reyhaneh ;
Behdani, Mahdi ;
Kazemi-Lomedasht, Fatemeh .
CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2022, 89 (02) :165-172
[6]   A nanobody-derived mimotope against VEGF inhibits cancer angiogenesis [J].
Karami, Elmira ;
Sabatier, Jean-Marc ;
Behdani, Mahdi ;
Irani, Shiva ;
Kazemi-Lomedasht, Fatemeh .
JOURNAL OF ENZYME INHIBITION AND MEDICINAL CHEMISTRY, 2020, 35 (01) :1233-1239
[7]   Two phase I studies of BI 836880, a vascular endothelial growth factor/angiopoietin-2 inhibitor, administered once every 3 weeks or once weekly in patients with advanced solid tumors [J].
Le Tourneau, C. ;
Becker, H. ;
Claus, R. ;
Elez, E. ;
Ricci, F. ;
Fritsch, R. ;
Silber, Y. ;
Hennequin, A. ;
Tabernero, J. ;
Jayadeva, G. ;
Luedtke, D. ;
He, M. ;
Isambert, N. .
ESMO OPEN, 2022, 7 (05)
[8]   VEGF and the diabetic kidney: More than too much of a good thing [J].
Majumder, Syamantak ;
Advani, Andrew .
JOURNAL OF DIABETES AND ITS COMPLICATIONS, 2017, 31 (01) :273-279
[9]   Angiogenesis Inhibitors in NSCLC [J].
Manzo, Anna ;
Montanino, Agnese ;
Carillio, Guido ;
Costanzo, Raffaele ;
Sandomenico, Claudia ;
Normanno, Nicola ;
Piccirillo, Maria Carmela ;
Daniele, Gennaro ;
Perrone, Francesco ;
Rocco, Gaetano ;
Morabito, Alessandro .
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2017, 18 (10)
[10]   A Randomized, Double-Masked, Multicenter Trial of Topical Acrizanib (LHA510), a Tyrosine Kinase VEGF-Receptor Inhibitor, in Treatment-Experienced Subjects With Neovascular Age-Related Macular Degeneration [J].
Poor, Stephen H. ;
Weissgerber, Georges ;
Adams, Christopher M. ;
Bhatt, Harit ;
Browning, David J. ;
Chastain, James ;
Ciulla, Thomas A. ;
Ferriere, Michael ;
Gedif, Kinfemichael ;
Glazer, Louis C. ;
Joondeph, Brian C. ;
Normand, Guillaume ;
Sheth, Veeral ;
Watters, Christie ;
Grosskreutz, Cynthia L. .
AMERICAN JOURNAL OF OPHTHALMOLOGY, 2022, 239 :180-189